Role of MSK1 in the signaling pathway leading to VEGF-mediated PAF synthesis in endothelial cells

Journal of Cellular Biochemistry

Volumn 98, Issue 5, 2006, Pages 1095-1105

  Marchand, Catherine ^a,b   Favier, Judith ^a,b   Sirois, Martin G ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiogenesis; Inflammation; MSK1; PAF; sPLA2 V; VEGF

Indexed keywords

COMPLEMENTARY DNA; DEAD KINASE MSK1; GROUP V SECRETORY PHOSPHOLIPASE A2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPILIN 1; PHOSPHOLIPASE A2; PHOSPHOTRANSFERASE; PLASMID DNA; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; AORTA; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; COW; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS;

BOS TAURUS;

EID: 33746444773     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20840     Document Type: Article

References (38)

1. Arthur JS, Cohen P. 2000. MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett 482(1-2):44-48.
2. Arthur JS, Fong AL, Dwyer JM, Davare M, Reese E, Obrietan K, Impey S. 2004. Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins. J Neurosci 24(18):4324-4332.
3. Baker PR, Owen JS, Nixon AB, Thomas LN, Wooten R, Daniel LW, O'Flaherty JT, Wykle RL. 2002. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. Biochim Biophys Acta 1592(2):175-184.
4. Bernatchez PN, Soker S, Sirois MG. 1999. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem 274(43):31047-31054.
5. Bernatchez PN, Allen BG, Gelinas DS, Guillemette G, Sirois MG. 2001a. Regulation of VEGF-induced endothelial cell PAF synthesis: Role of p42/44 MAPK, p38 MAPK and PI3K pathways. Br J Pharmacol 134(6):1253-1262.
6. Bernatchez PN, Winstead MV, Dennis EA, Sirois MG. 2001b. VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. Br J Pharmacol 134(1):197-205.
7. Bernatchez PN, Rollin S, Soker S, Sirois MG. 2002. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. J Cell Biochem 85(3):629-639.
8. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37(8):911-917.
9. Bussolino F, Camussi G. 1995. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur J Biochem 229(2):327-337.
10. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. 1989. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84(5):1470-1478.
11. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364(2):229-233.
12. Deak M, Clifton AD, Lucocq LM, Alessi DR. 1998. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. Embo J 17(15):4426-4441.
13. Delghandi MP, Johannessen M, Moens U. 2005. The cAMP signaling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal 17(11):1343-1351.
14. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92(17):7686-7689.
15. Dunn KL, Espino PS, Drobic B, He S, Davie JR. 2005. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol 83(1):1-14.
16. Dvorak HF, Brown LF, Detmar M, Dvorak AM. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146(5):1029-1039.
17. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18(1):4-25.
18. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16(9):4604-4613.
19. Frodin M, Gammeltoft S. 1999. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151(1-2):65-77.
20. Frodin M, Antal TL, Dummler BA, Jensen CJ, Deak M, Gammeltoft S, Biondi RM. 2002. A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. Embo J 21(20):5396-5407.
21. Hefner Y, Borsch-Haubold AG, Murakami M, Wilde JI, Pasquet S, Schieltz D, Ghomashchi F, Yates JR 3rd, Armstrong CG, Paterson A, Cohen P, Fukunaga R, Hunter T, Kudo I, Watson SP, Gelb MH. 2000. Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases. J Biol Chem 275(48):37542-37551.
22. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72(2):269-278.
23. Markou T, Lazou A. 2002. Phosphorylation and activation of mitogen- and stress-activated protein kinase-1 in adult rat cardiac myocytes by G-protein-coupled receptor agonists requires both extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase. Biochem J 365(Pt 3):757-763.
24. Mayo LD, Kessler KM, Pincheira R, Warren RS, Donner DB. 2001. Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase. J Biol Chem 276(27):25184-25189.
25. McCoy CE, Campbell DG, Deak M, Bloomberg GB, Arthur JS. 2005. MSK1 activity is controlled by multiple phosphorylation sites. Biochem J 387(Pt 2):507-517.
26. Montrucchio G, Lupia E, Battaglia E, Del Sorbo L, Boccellino M, Biancone L, Emanuelli G, Camussi G. 2000. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol 20(1):80-88.
27. Nemenoff RA, Winitz S, Qian NX, Van Putten V, Johnson GL, Heasley LE. 1993. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 268(3):1960-1964.
28. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 13(1):9-22.
29. Nixon AB, O'Flaherty JT, Salyer JK, Wykle RL. 1999. Acetyl-CoA:1-O-alkyl- 2-lyso-sn-glycero-3-phosphocholine acetyltransferase is directly activated by p38 kinase. J Biol Chem 274(9):5469-5473.
30. Owen JS, Baker PR, O'Flaherty JT, Thomas MJ, Samuel MP, Wooten RE, Wykle RL. 2005. Stress-induced platelet-activating factor synthesis in human neutrophils. Biochim Biophys Acta 1733(2-3):120-129.
31. Pierrat B, Correia JS, Mary JL, Tomas-Zuber M, Lesslauer W. 1998. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alpha-MAPK). J Biol Chem 273(45):29661-29671.
32. Rakhit S, Clark CJ, O'Shaughnessy CT, Morris BJ. 2005. N-methyl-D-aspartate and brain-derived neurotrophic factor induce distinct profiles of extracellular signal-regulated kinase, mitogen- and stress-activated kinase, and ribosomal s6 kinase phosphorylation in cortical neurons. Mol Pharmacol 67(4):1158-1165.
33. Shaywitz AJ, Greenberg ME. 1999. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821-861.
34. Sirois MG, Edelman ER. 1997. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol 272(6 Pt 2):H2746-2756.
35. Snyder F, Fitzgerald V, Blank ML. 1996. Biosynthesis of platelet-activating factor and enzyme inhibitors. Adv Exp Med Biol 416:5-10.
36. Tomas-Zuber M, Mary JL, Lamour F, Bur D, Lesslauer W. 2001. C-terminal elements control location, activation threshold, and p38 docking of ribosomal S6 kinase B (RSKB). J Biol Chem 276(8):5892-5899.
37. Webber KM, Smith MA, Lee HG, Harris PL, Moreira P, Perry G, Zhu X. 2005. Mitogen- and stress-activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease. J Neurosci Res 79(4):554-560.
38. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS. 2002. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 22(8):2871-2881.